Shanghai Pharmaceuticals (SHPMF) Stock Price, News & Analysis

Company Overview

Shanghai Pharmaceuticals (OTCMKTS: SHPMF) is a leading integrated healthcare company headquartered in Shanghai, China. Established in 1994 through the consolidation of state‐owned pharmaceutical entities, the firm has built a comprehensive business model spanning pharmaceutical distribution, manufacturing and retail pharmacy services. The company’s core distribution network delivers prescription and over‐the‐counter medications, medical devices and healthcare products to hospitals, clinics and community pharmacies across mainland China.

In its manufacturing segment, Shanghai Pharmaceuticals produces active pharmaceutical ingredients (APIs), finished dosage forms and chemical intermediates. The company’s research and development arm focuses on both generic and innovative therapies, with a pipeline that addresses major therapeutic areas such as cardiovascular, oncology and central nervous system disorders. With multiple production sites certified to international quality standards, Shanghai Pharmaceuticals supports domestic demand and exports to select Asian and African markets under strategic partnerships.

On the retail side, the company operates a chain of community pharmacies under the “Shanghai Pharma” brand, providing healthcare advice, prescription fulfillment and wellness services to end users. Over the years, Shanghai Pharmaceuticals has pursued targeted acquisitions and alliances to strengthen its supply‐chain capabilities and broaden its product offering. Led by an experienced executive team and overseen by a board of directors with deep industry expertise, the company continues to expand its footprint in China’s healthcare sector and enhance its R&D and commercial platforms.

Key Stats

• Today's Range: $1.53 to $1.53
• 50-Day Range: $1.53 to $1.56
• 52-Week Range: $0.99 to $1.95
• Volume: N/A
• Average Volume: 33,943 shs
• Market Capitalization: N/A
• P/E Ratio: 1.64
• Dividend Yield: 17.22%
• Price Target: N/A
• Consensus Rating: N/A

SHPMF Stock Analysis - Frequently Asked Questions

How have SHPMF shares performed this year?

Shanghai Pharmaceuticals' stock was trading at $1.64 at the beginning of 2025. Since then, SHPMF shares have decreased by 6.7% and is now trading at $1.53.

How do I buy shares of Shanghai Pharmaceuticals?

Shares of SHPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SHPMF
• CIK: 1570300
• Web: www.sphchina.com
• Phone: 86-21-6373-0908
• Fax: N/A
• Employees: 49,234
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.64
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A